The US patient monitoring market is projected to grow over $5 billion by 2020 driven by the demand for customized healthcare solutions, increased chronic illness amongst the aging population, and strained healthcare budgets.
The US telehealth market is expected to lead growth in the patient monitoring market, which is projected to grow over $5 billion by 2020, according to a report by iData Research. The telehealth market is segmented into cardiac implantable electric device telehealth monitoring and disease conditions management telehealth monitoring, which should represent more than half of the total telehealth market by 2020.
Growth in the telehealth market will be driven by the demand for customized healthcare solutions, increased chronic illness amongst the aging population, and strained healthcare budgets, according to the report. In addition, market growth is expected to be further bolstered as awareness and implementation of standards for reimbursement and adoption of this type of care management increase.
Read the press release: http://on.mktw.net/1ysjEIf
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
Examining Telehealth Uptake to Increase Equitable Care Access
January 26th 2023To mark the publication of The American Journal of Managed Care®’s 12th annual health IT issue, on this episode of Managed Care Cast, we speak with Christopher M. Whaley, PhD, health care economist at the RAND Corporation, who focuses on health economics issues, including the influence of the COVID-19 pandemic on health care delivery.
Listen
Researchers Identify Potential Biomarkers for SMA Motor Improvement Following Nusinersen Treatment
November 17th 2023A retrospective, exploratory analysis identifies biomarkers predictive of spinal muscular atrophy (SMA) response to nusinersen and suggests the efficacy of using machine learning algorithms to anticipate patient outcomes.
Read More